Apr 25, 2022 7:00am EDT NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay
Apr 11, 2022 10:00am EDT NeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
Apr 11, 2022 7:00am EDT NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
Apr 08, 2022 4:05pm EDT NeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
